DaVita Inc (DVA)
145.31
+0.37
(+0.26%)
USD |
NYSE |
Nov 05, 11:23
DaVita Enterprise Value: 22.19B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 22.19B |
| November 01, 2024 | 21.91B |
| October 31, 2024 | 21.77B |
| October 30, 2024 | 21.88B |
| October 29, 2024 | 23.28B |
| October 28, 2024 | 23.18B |
| October 25, 2024 | 23.17B |
| October 24, 2024 | 23.63B |
| October 23, 2024 | 23.75B |
| October 22, 2024 | 23.78B |
| October 21, 2024 | 23.64B |
| October 18, 2024 | 23.68B |
| October 17, 2024 | 23.53B |
| October 16, 2024 | 23.92B |
| October 15, 2024 | 23.90B |
| October 14, 2024 | 23.67B |
| October 11, 2024 | 23.59B |
| October 10, 2024 | 23.47B |
| October 09, 2024 | 23.46B |
| October 08, 2024 | 23.05B |
| October 07, 2024 | 23.31B |
| October 04, 2024 | 23.57B |
| October 03, 2024 | 23.44B |
| October 02, 2024 | 23.44B |
| October 01, 2024 | 23.74B |
| Date | Value |
|---|---|
| September 30, 2024 | 23.84B |
| September 27, 2024 | 24.03B |
| September 26, 2024 | 23.96B |
| September 25, 2024 | 24.11B |
| September 24, 2024 | 23.90B |
| September 23, 2024 | 23.90B |
| September 20, 2024 | 24.10B |
| September 19, 2024 | 24.03B |
| September 18, 2024 | 24.03B |
| September 17, 2024 | 24.12B |
| September 16, 2024 | 24.20B |
| September 13, 2024 | 24.07B |
| September 12, 2024 | 23.57B |
| September 11, 2024 | 23.26B |
| September 10, 2024 | 23.23B |
| September 09, 2024 | 22.95B |
| September 06, 2024 | 22.93B |
| September 05, 2024 | 22.82B |
| September 04, 2024 | 23.04B |
| September 03, 2024 | 23.10B |
| August 30, 2024 | 23.01B |
| August 29, 2024 | 23.20B |
| August 28, 2024 | 23.23B |
| August 27, 2024 | 23.34B |
| August 26, 2024 | 23.33B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.07B
Minimum
Nov 09 2022
24.20B
Maximum
Sep 16 2024
19.83B
Average
19.28B
Median
Dec 19 2023
Enterprise Value Benchmarks
| Quest Diagnostics Inc | 22.82B |
| Encompass Health Corp | 13.29B |
| Universal Health Services Inc | 18.57B |
| HCA Healthcare Inc | 135.03B |
| Boston Scientific Corp | 133.49B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 214.69M |
| Revenue (Quarterly) | 3.264B |
| Total Expenses (Quarterly) | 2.732B |
| EPS Diluted (Quarterly) | 2.50 |
| Gross Profit Margin (Quarterly) | 34.06% |
| Profit Margin (Quarterly) | 6.58% |
| Earnings Yield | 6.38% |
| Operating Earnings Yield | 14.49% |
| Normalized Earnings Yield | 6.439 |